What is King Pharmaceuticals's dividends paid?

King Pharmaceuticals (KG) reported dividends paid of $10M in Q4 2025.

What does dividends paid mean?

Total cash dividends paid to common stockholders, reflecting the company's capital return policy.

King Pharmaceuticals KG Dividends Paid

Discontinued — last reported Q4 '25

Dividends Paid at other companies

Everest GroupEG

$80M-5.9%

KKR & Co.KKR

$164.81M+6.0%

Selective Insurance GroupSIGI

$24.84M+11.6%

Reinsurance Group of AmericaRGA

$61M+3.4%

Verisk Analytics, Inc.VRSK

$65.5M+4.0%

Tiptree Inc.TIPT

——

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-67.6%

Enterprise value$184.93M-50.0%

P/E1.2×—

P/S1.6×-24.3×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PaymentsOfDividendsCommonStock.

The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's dividends paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's dividends paid?: King Pharmaceuticals (KG) reported dividends paid of $10M in Q4 2025.
What does dividends paid mean?: Total cash dividends paid to common stockholders, reflecting the company's capital return policy.